An expert discusses treatment strategies for immune thrombocytopenic purpura (ITP), emphasizing individualized decisions based on platelet count, bleeding symptoms, and comorbidities, with options ...

Hormone receptor-positive (HR+) breast cancer is the most prevalent subtype of breast cancer in both early- and advanced-stage disease. Moreover, the treatment of HR+ breast cancer has had the ...

Treatment Algorithms for Hormone Receptor-Positive Advanced Breast Cancer: Applying the Results from Recent Clinical Trials into Daily Practice—Insights, Limitations, and Moving Forward Treating ...

Dr Haumschild leads a discussion surrounding the latest advancements in treatment algorithms for myelodysplastic syndrome. The discussion centered on diverse treatment strategies for myelodysplastic ...

MUSC Children's Health hematologists/oncologists Dr. Michelle Hudspeth (left) and Dr. Shayla Bergmann (right) conducted a study of a new algorithm to standardize the ...

PharmaEssentia Announces Updated NCCN Clinical Practice Guidelines Include ropeginterferon alfa-2b-njft (BESREMi®) for Treatment of Essential Thrombocythemia (ET), by . PharmaEssentia USA Corporation.

Please provide your email address to receive an email when new articles are posted on . Researchers have proposed a machine-learning algorithm for personalized treatment selection in patients with ...

Please provide your email address to receive an email when new articles are posted on . An algorithm is a set of instructions for solving a problem or accomplishing a task. One common example of an ...